
Devonian Health Group Inc.
Devonian Health Group Inc.(DVHGF)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · DVHGF · 截至 Jun 9, 2026
关键指标
探索 Devonian Health Group Inc. 数据
dvhgf stock data · financials财务快照
完整财报竞争对手与同行
dvhgf competitors股票表现
完整历史关于 Devonian Health Group Inc.
Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat con…
what is devonian health group inc. · dvhgf stock overview · devonian health group inc. company profile · who is devonian health group inc. ceo · dvhgf OTC · devonian health group inc. headquarters · devonian health group inc. business segments
关于股票概览与关键数据
Devonian Health Group Inc.(DVHGF)是 Biotechnology 行业的 Healthcare 类公司,于 Sep 19, 2022 在 OTC 上市。截至最近交易日,DVHGF 股价为 $10.65,市值约为 $29.6M。过去12个月累计回报 -1.39%,年初至今回报 +149.41%。
2025 财年 Devonian Health Group Inc. 营收 $17.0M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。
常见问题
截至最近一个交易日,Devonian Health Group Inc.(DVHGF)股价为 $10.65,在 OTC 上市,52周区间为 $4.27 – $10.80。